Slow-growing melanomas lose structure, vary color with time

June 1, 2012
Slow-Growing melanomas lose structure, vary color with time
The diameter of most slow-growing melanomas changes very little over time, but the lesions can become more disorganized, less structured, and change or develop new colors, according to a study published in the June issue of the British Journal of Dermatology.

(HealthDay) -- The diameter of most slow-growing melanomas (SGMs) changes very little over time, but the lesions can become more disorganized, less structured, and change or develop new colors, according to a study published in the June issue of the British Journal of Dermatology.

Vitaly Terushkin, M.D., of Memorial Sloan-Kettering Cancer Center in New York City, and colleagues retrospectively assessed a dermoscopic image dataset of 92 SGMs from 15 pigmented lesion clinics that were sequentially followed for one year or more. Changes in global pattern, organization, color, structure, and were evaluated at baseline and follow-up.

The researchers found that, on follow-up, the dermoscopic pattern of the melanomas became more homogeneous and less reticular; the melanomas had more frequent disorganization of pattern; there was a reduction in the prominence of dermoscopic structure of pigmented network and a simultaneous increase in the prominence of areas with no structure; and they developed more melanoma-specific dermoscopic structures. Color changes included a decrease in light brown and increases in the prominence of dark brown and the frequency of new (red, white, grey, blue, and black). Seventy-five percent of grew by less than 2 mm or remained the same size; an increase in size correlated with the total number of colors and structures.

"Physicians should pay particular attention to melanocytic lesions that, over time, become more disorganized, reveal a loss of network in favor of structureless areas, develop a negative network, and exhibit new colors such as dark brown, black, grey, blue, red, and white; in addition, one should not rely solely on change in size," the authors write.

Explore further: Melanoma screening by physicians associated with finding more cancers than patient self-detection

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

Patients referred to dermatologists skin lesions evaluations also found to have other skin cancers

May 16, 2011
Among patients referred by non-dermatologists to dermatologists for evaluation of skin lesions suspected of being malignant, only apparently one-fifth were found to be cancerous, although dermatologists identified and biopsied ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.